In this study, we investigated the effects of LY2405319, an FGF21 analogue, on the succinate-GPR91 pathway in HSC activation, using LX-2 cells and an MCD diet–induced mouse model of NAFLD. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.